Ian White

Ian White

Chief Executive Officer and Chief Scientific Officer

Professional Information

OrganizationNeobiosis, LLC, MCI, Ways2Well
CountryUSA
Member SinceJanuary 30, 2026

Biography

Dr. White is widely recognized as a leading expert in aging and regenerative medicine. He earned his Ph.D. in biophysics from the Ansary Stem Cell Institute in the Division of Regenerative Medicine at Cornell University and completed postdoctoral training at the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine, where he published pioneering research on the role of biochemical signaling in cardiac regeneration. Dr. White is the CEO and CSO of Neobiosis, a perinatal regenerative tissue research and manufacturing company, and also serves as CSO for Ways2Well, a pioneering health and wellness clinic. He is the Vice President and a member of the Board of Directors of the American College of Regenerative Medicine. Additionally, he serves on the scientific advisory boards of the Alliance for Longevity Initiatives (A4Li), the Healthspan Action Coalition and MUSE cell Innovations. The government of the Bahamas recently appointed Dr. White to the Ethics Committee for the Longevity and Regenerative Therapy Act (LARTA). He is also the founder of the Space-Aging Research Institute (SARI) where he studies the physics of human aging (eA).

Specialization

Regenerative Medicine, Stem Cells, Aging, Cellular Therapy, Cardiac Regeneration

Education

Cornell University (2008) Ph.D. – Ansary Stem Cell Institute, Division of Regenerative Medicine.

Liverpool School of Tropical Medicine, UK (1999) Master of Science.

Liverpool John Moores University, UK (1998) Bachelor of Science.

Research & Publications

https://www.linkedin.com/in/ian-white-phd/details/publications